The Current Ratio as of September 2024 (TTM) for Evaxion Biotech A/S (EVAX) is 2.80

According to Evaxion Biotech A/S’s latest financial reports and current stock price. The company's current Current Ratio is 2.80. This represents a change of 147.01% compared to the average of 1.13 of the last 4 quarters.

Evaxion Biotech A/S (EVAX) Historical Current Ratio (quarterly & annually)

How has EVAX Current Ratio performed in the past?

The mean historical Current Ratio of Evaxion Biotech A/S over the last ten years is 4.34. The current 2.80 Current Ratio has changed 6.35% with respect to the historical average. Over the past ten years (40 quarters), EVAX's Current Ratio was at its highest in in the December 2021 quarter at 8.03. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Evaxion Biotech A/S (EVAX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Evaxion Biotech A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evaxion Biotech A/S (EVAX) Average Current Ratio

How has EVAX Current Ratio performed in the past?

The current Current Ratio of Evaxion Biotech A/S (EVAX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Evaxion Biotech A/S (EVAX) Current Ratio vs. Peers

How is EVAX’s Current Ratio compared to its peers?

Evaxion Biotech A/S’s Current Ratio is greater than Sigilon Therapeutics, Inc. (1.78), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than ZyVersa Therapeutics, Inc. (0.06), greater than Kiromic BioPharma, Inc. (0.35), less than Unicycive Therapeutics, Inc. (3.37), less than Quoin Pharmaceuticals, Ltd. (3.35), greater than Allarity Therapeutics, Inc. (2.01), less than Virax Biolabs Group Limited (25.94), greater than Biodexa Pharmaceuticals Plc (1.26), less than Lyell Immunopharma, Inc. (16.19), less than Cullinan Oncology, Inc. (28.87), less than Monte Rosa Therapeutics, Inc. (6.56), less than Theseus Pharmaceuticals, Inc. (29.93), less than Revolution Medicines, Inc. (15.42), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Landos Biopharma, Inc. (4.43), greater than Apexigen, Inc. (0.82), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Angion Biomedica Corp. (1.74), greater than Revelation Biosciences, Inc. (1.10), less than Zura Bio Limited (12.57), less than Phio Pharmaceuticals Corp. (3.47), greater than TransCode Therapeutics, Inc. (1.25),

Build a custom stock screener for Evaxion Biotech A/S (EVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evaxion Biotech A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evaxion Biotech A/S (EVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evaxion Biotech A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.